PTC Therapeutics Inc (NASDAQ:PTCT)

26.03
Delayed Data
As of 4:00pm ET
 -0.20 / -0.76%
Today’s Change
10.65
Today|||52-Week Range
33.22
+56.06%
Year-to-Date
No recent news for PTC Therapeutics Inc.

Today’s Trading

Previous close26.23
Today’s open26.22
Day’s range25.25 - 26.76
Volume588,106
Average volume (3 months)944,998
Market cap$1.2B
Data as of 4:00pm ET, 04/23/2018

Growth & Valuation

Earnings growth (last year)+51.56%
Earnings growth (this year)+57.73%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)+135.04%
P/E ratioNM
Price/Sales3.36
Price/Book7.66

Competitors

 Today’s
change
Today’s
% change
KERXKeryx Biopharmaceuti...-0.23-4.83%
TGTXTG Therapeutics Inc-0.35-2.43%
BYSIBeyondspring Inc-1.10-3.54%
EGRXEagle Pharmaceutical...+0.08+0.15%
Data as of 4:00pm ET, 04/23/2018

Financials

Next reporting dateMay 7, 2018
EPS forecast (this quarter)-$0.69
Annual revenue (last year)$194.4M
Annual profit (last year)-$79.0M
Net profit margin-40.64%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Stuart W. Peltz
Chief Operating Officer
Marcio Souza
Corporate headquarters
South Plainfield, New Jersey

Forecasts